Hepatitis C and HIV co-infection: A review

World Journal of Gastroenterology

Volumn 8, Issue 4, 2002, Pages 577-579

  Maier, Irena ^a   Wu, George Y ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON PLUS RIBAVIRIN; AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; EFAVIRENZ; INDINAVIR; INTERFERON; INTERFERON PLUS MACROGOL; INTERLEUKIN 10; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RIBAVIRIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; UNCLASSIFIED DRUG; VIRUS DNA; ZIDOVUDINE;

ANEMIA; BLOOD TRANSFUSION; DISEASE COURSE; DISEASE TRANSMISSION; DOSE TIME EFFECT RELATION; DRUG ABUSE; DRUG ANTAGONISM; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HEPATITIS C; HEPATITIS C VIRUS; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPERBILIRUBINEMIA; INTRAVENOUS DRUG ABUSE; LIVER TOXICITY; LYMPHOCYTE COUNT; NONHUMAN; PATHOPHYSIOLOGY; PHOSPHORYLATION; POPULATION RESEARCH; PREVALENCE; REVIEW; RISK FACTOR; SUPERINFECTION; TREATMENT PLANNING; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0036679455     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i4.577     Document Type: Review

References (32)

1. Hepatitis C and human immunodeficiency virus co-infections
2. A multicenter study of viral hepatitis in a United States hemophilic population
3. Increased transmission of vertical hepatitis C virus (HCV) infection to human immunodeficiency virus (HIV)-infected infants of HIV- and HCV-co-infected women
4. Hepatitis C in HIV-infected patients with and without AIDS: Prevalence and relationship to patient survival
5. Hepatitis C in patients with human immunodeficiency virus infection: Diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues
6. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value
7. The epidemiology of hepatitis C virus and HIV
8. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin
9. Hepatitis C virus infection in a large cohort of homosexually active men: Independent associations with HIV-1 infection and injecting drug use but not sexual behavior
10. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV)
11. Basic virology of HIV and HCV: Parallels and contrasts?
12. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users
13. The MultivirC Group. Factors affecting liver fibrosis in human immunodeficiency virus - and hepatitis C virus - co-infected patients: Impact of protease inhibitor therapy
14. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis
15. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus co-infected patients
16. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters
17. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The hepatitis/HIV Spanish Study Group
18. Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: A case-control study. The MULTIVIRC group
19. Does HIV-infection influence the response of chronic hepatitis C to interferon treatment? A French multicenter prospective study
20. Hepatitis C virus and human immunodeficiency virus: Clinical issues in co-infection
21. Immune responses against HIV and HCV: What lessons can we learn from these different viruses?
22. Hepatitis C virus/human immunodeficiency virus co-infection: Clinical management issues
23. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis - HIV Spanish Study Group
24. Efficacy and safety of combination therapy with interferon-alpha 2b and ribavirin for chronic hepatitis C in HIV-infected patients
25. Diagnosis and management of the HCV/HIV - Co-infected patient
26. Interferon plus ribavirin for chronic hepatitis C in HIV-infected patients
27. Chronic hepatitis C in HIV infection: Feasibility and sustained efficacy of therapy with interferon alpha-2b and ribavirin
28. A controlled, randomized, multicenter, descending dose phase II trial of pegylated interferon alfa-2A (PEG) vs standard interferon alfa-2A (IFN) for treatment of chronic hepatitis C
29. Peginterferon alfa-2a in patients with chronic hepatitis C
30. Pegylated interferon alfa-2A (Pegasys) and ribavirin combination therapy for chronic hepatitis C: A phase II open label study
31. Management issues in patients co-infected with hepatitis C and HIV
32. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection